Showing 1 - 10 of 72,741
explored in an in-depth qualitative examination of sourcing practices in drug development. The outsourcing of central … biotechnology firms, I explain why outsourcing deals take the form of embedded relationships in the first setting, and of seemingly …
Persistent link: https://www.econbiz.de/10013239192
explored in an in-depth qualitative examination of sourcing practices in drug development. The outsourcing of central … biotechnology firms, I explain why outsourcing deals take the form of embedded relationships in the first setting, and of seemingly …
Persistent link: https://www.econbiz.de/10012468552
Persistent link: https://www.econbiz.de/10001825856
This paper examines how a radical technological innovation affects alliance formation of firms and subsequent network structures. We use longitudinal data of interfirm R&D collaborations in the biopharmaceutical industry in which a new technological regime is established. Our findings suggest...
Persistent link: https://www.econbiz.de/10011372508
This paper analyses the inter-firm R&D network formed in the pharmaceutical biotechnology industry during the 1990s from different perspectives: theoretical network formation, firm's structural positions and its collaborations at the entire network level, and the determinants for firm's...
Persistent link: https://www.econbiz.de/10009751604
In order to explain why innovation activities are increasingly structuring through networking and agglomeration dynamics, numerous empirical and theoretical works in various disciplines (economics, geography, sociology, management) have stressed the crucial role of spatial proximity. Following...
Persistent link: https://www.econbiz.de/10012712468
Prior research on corporate headquarters (CHQ) characteristics identifies the impact of CHQ location and composition on the innovation outcomes of internal subsidiaries. However, given that external strategic alliances with high-tech entrepreneurial firms represent a key source of innovation for...
Persistent link: https://www.econbiz.de/10012131396
Based on the case of the biopharmaceutical industry, the aim of this paper is to challenge the core conviction now widespread within the “spatial clustering theory”, which devotes a key (if not exclusive) role to geographical proximity in explaining clustering dynamics of innovation...
Persistent link: https://www.econbiz.de/10014204164
Despite sustained interest in product alliance activity, little is known regarding the effect of product alliances on shareholder value. Whereas proponents of alliances justify their formation by emphasizing access to relevant resources and know-how, critics highlight the risks inherent in...
Persistent link: https://www.econbiz.de/10014144306
Persistent link: https://www.econbiz.de/10011545151